ArticleEuropean radiology2026
Comparison of three algorithms to measure breast density on mammograms in a population-based screening cohort.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
objectivesTo compare breast density assessments from three automated algorithms by evaluating their agreement and associations with breast cancer risk in a large screening population. MATERIALS AND
methodsWe included 61,514 women from the Dutch population-based PRISMA screening cohort (2014-2019). Breast density was quantified on one screening mammogram per participant using Volpara Density Grade 4th and 5th edition, Quantra Density Assessment Software, and iCAD Density Assessment. Agreement between categorical outputs was assessed via weighted kappa statistics. Breast cancer cases were identified through linkage with the Netherlands Cancer Registry (follow-up until December 2022). Associations with five-year breast cancer risk were analyzed using Cox proportional hazards models. Discriminative ability was evaluated using the area under the receiver operating characteristic curve (AUC).
resultsGood agreement was observed between algorithms (kappa: 0.725-0.826); the strongest across-vendor agreement was between Volpara Density Grade 5th edition and Quantra Density Assessment Software (kappa = 0.795). However, the proportion of women classified with extremely dense breasts (category D) varied (3.1-8.4%). During a median follow-up of 4.2 years, 777 breast cancer cases were identified. Both breast cancer risk and interval cancer risk increased with higher density, with similar magnitudes across algorithms. Categorical measures yielded similar AUCs to distinguish between women with and without breast cancer (0.53-0.55) and between screen-detected and interval cancers (0.57-0.60).
conclusionThree automated density assessment algorithms show strong agreement and comparable associations with breast cancer risk. However, differences in categorization-particularly the proportions classified as entirely fatty or extremely dense-should be considered in personalized screening strategies, as these may influence the capacity needed for potential supplemental screening. KEY POINTS: Question How do three automated breast density measurement algorithms compare in terms of agreement and their association with breast cancer risk in a large screening cohort? Findings The three algorithms showed strong agreement (kappa = 0.725-0.826) and similar associations with breast cancer risk. Proportions of mammograms classified as density categories A or D varied. Clinical relevance The strong agreement and similar associations with breast cancer risk support algorithm interchangeability, but variations in the proportion of mammograms classified as entirely fatty (category A) or extremely dense (category D) may impact capacity requirements for personalized screening.
Indexed as
Identifiers
42268306What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.